125 related articles for article (PubMed ID: 7776820)
1. Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids.
Xie XQ; Eissenstat M; Makriyannis A
Life Sci; 1995; 56(23-24):1963-70. PubMed ID: 7776820
[TBL] [Abstract][Full Text] [Related]
2. High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2.
Xie XQ; Han XW; Chen JZ; Eissenstat M; Makriyannis A
J Med Chem; 1999 Oct; 42(20):4021-7. PubMed ID: 10514272
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).
Dutta AK; Ryan W; Thomas BF; Singer M; Compton DR; Martin BR; Razdan RK
Bioorg Med Chem; 1997 Aug; 5(8):1591-600. PubMed ID: 9313864
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
Shim JY; Collantes ER; Welsh WJ; Subramaniam B; Howlett AC; Eissenstat MA; Ward SJ
J Med Chem; 1998 Nov; 41(23):4521-32. PubMed ID: 9804691
[TBL] [Abstract][Full Text] [Related]
5. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
Reggio PH; Basu-Dutt S; Barnett-Norris J; Castro MT; Hurst DP; Seltzman HH; Roche MJ; Gilliam AF; Thomas BF; Stevenson LA; Pertwee RG; Abood ME
J Med Chem; 1998 Dec; 41(26):5177-87. PubMed ID: 9857088
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of analogs of indole-based cannabimimetic agents.
Mazzoni O; Diurno MV; di Bosco AM; Novellino E; Grieco P; Esposito G; Bertamino A; Calignano A; Russo R
Chem Biol Drug Des; 2010 Jan; 75(1):106-14. PubMed ID: 19895505
[TBL] [Abstract][Full Text] [Related]
7. Conformational studies on a diastereoisomeric pair of tricyclic nonclassical cannabinoids by NMR spectroscopy and computer molecular modeling.
Xie XQ; Pavlopoulos S; DiMeglio CM; Makriyannis A
J Med Chem; 1998 Jan; 41(2):167-74. PubMed ID: 9457240
[TBL] [Abstract][Full Text] [Related]
8. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.
Aung MM; Griffin G; Huffman JW; Wu M; Keel C; Yang B; Showalter VM; Abood ME; Martin BR
Drug Alcohol Depend; 2000 Aug; 60(2):133-40. PubMed ID: 10940540
[TBL] [Abstract][Full Text] [Related]
9. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics.
Eissenstat MA; Bell MR; D'Ambra TE; Alexander EJ; Daum SJ; Ackerman JH; Gruett MD; Kumar V; Estep KG; Olefirowicz EM
J Med Chem; 1995 Aug; 38(16):3094-105. PubMed ID: 7636873
[TBL] [Abstract][Full Text] [Related]
10. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles.
Jansen EM; Haycock DA; Ward SJ; Seybold VS
Brain Res; 1992 Mar; 575(1):93-102. PubMed ID: 1504787
[TBL] [Abstract][Full Text] [Related]
11. Conformational analysis of the prototype nonclassical cannabinoid CP-47,497, using 2D NMR and computer molecular modeling.
Xie XQ; Yang DP; Melvin LS; Makriyannis A
J Med Chem; 1994 May; 37(10):1418-26. PubMed ID: 8182700
[TBL] [Abstract][Full Text] [Related]
12. 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.
Huffman JW; Mabon R; Wu MJ; Lu J; Hart R; Hurst DP; Reggio PH; Wiley JL; Martin BR
Bioorg Med Chem; 2003 Feb; 11(4):539-49. PubMed ID: 12538019
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes.
Huffman JW; Padgett LW
Curr Med Chem; 2005; 12(12):1395-411. PubMed ID: 15974991
[TBL] [Abstract][Full Text] [Related]
14. Cannabimimetic indoles, pyrroles and indenes.
Huffman JW
Curr Med Chem; 1999 Aug; 6(8):705-20. PubMed ID: 10469887
[TBL] [Abstract][Full Text] [Related]
15. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
Martin BR; Compton DR; Thomas BF; Prescott WR; Little PJ; Razdan RK; Johnson MR; Melvin LS; Mechoulam R; Ward SJ
Pharmacol Biochem Behav; 1991 Nov; 40(3):471-8. PubMed ID: 1666911
[TBL] [Abstract][Full Text] [Related]
16. Aminoalkylindoles (AAIs): a new route to the cannabinoid receptor?
Ward SJ; Baizman E; Bell M; Childers S; D'Ambra T; Eissenstat M; Estep K; Haycock D; Howlett A; Luttinger D
NIDA Res Monogr; 1990; 105():425-6. PubMed ID: 1908557
[No Abstract] [Full Text] [Related]
17. WIN55212-2 docking to the CB1 cannabinoid receptor and multiple pathways for conformational induction.
Shim JY; Howlett AC
J Chem Inf Model; 2006; 46(3):1286-300. PubMed ID: 16711748
[TBL] [Abstract][Full Text] [Related]
18. A rational search for the separation of psychoactivity and analgesia in cannabinoids.
Reggio PH; McGaughey GB; Odear DF; Seltzman HH; Compton DR; Martin BR
Pharmacol Biochem Behav; 1991 Nov; 40(3):479-86. PubMed ID: 1806940
[TBL] [Abstract][Full Text] [Related]
19. Arthritis and cannabinoids: HU-210 and Win-55,212-2 prevent IL-1alpha-induced matrix degradation in bovine articular chondrocytes in-vitro.
Mbvundula EC; Bunning RA; Rainsford KD
J Pharm Pharmacol; 2006 Mar; 58(3):351-8. PubMed ID: 16536902
[TBL] [Abstract][Full Text] [Related]
20. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
Kuster JE; Stevenson JI; Ward SJ; D'Ambra TE; Haycock DA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1352-63. PubMed ID: 8450470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
